
Autologous platelet-rich plasma use reveals no benefit in improving pain and function

Autologous platelet-rich plasma use reveals no benefit in improving pain and function
Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis
J Bone Joint Surg Am. 2012 Feb 15;94(4):298-307. doi: 10.2106/JBJS.K.00154Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
23 randomized controlled trials (RCTs) and 10 prospective cohort studies were identified to evaluate the efficacy of autologous blood concentrates in decreasing pain and improving healing and function for patients with orthopaedic bone and soft-tissue injuries. Results from both types of studies indicated that the use of platelet-rich plasma provided no significant benefit up to and including 24 m...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.